✦ LIBER ✦

Quantitative MRI measures of orbitofrontal cortex in patients with chronic schizophrenia or schizoaffective disorder

✍ Scribed by Matthew J. Hoptman; Jan Volavka; Elisabeth M. Weiss; Pál Czobor; Philip R. Szeszko; Guido Gerig; Miranda Chakos; Joseph Blocher; Leslie L. Citrome; Jean-Pierre Lindenmayer; Brian Sheitman; Jeffrey A. Lieberman; Robert M. Bilder

Book ID: 113866020
Publisher: Elsevier Science
Year: 2005
Tongue: English
Weight: 264 KB
Volume: 140
Category: Article
ISSN: 0925-4927
DOI: 10.1016/j.pscychresns.2005.07.004

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Self-report and laboratory measures of i

Self-report and laboratory measures of impulsivity in patients with schizophrenia or schizoaffective disorder and healthy controls

✍ Karen A. Nolan; Debra D'Angelo; Matthew J. Hoptman 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 139 KB

Prevalence of metabolic syndrome among p

Prevalence of metabolic syndrome among patients with schizophrenia or schizoaffective disorder in Taiwan

✍ M.-C. Huang; M.-L. Lu; C.-J. Tsai; P.-Y. Chen; C.-C. Chiu; D.-L. Jian; K.-M. Lin 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 180 KB

Risperidone versus olanzapine in the tre

Risperidone versus olanzapine in the treatment of patients with schizophrenia or schizoaffective disorder

✍ M. Brecher 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 167 KB

Cognitive and antismoking effects of var

Cognitive and antismoking effects of varenicline in patients with schizophrenia or schizoaffective disorder

✍ Robert C. Smith; Jean-Pierre Lindenmayer; John M. Davis; James Cornwell; Kathryn 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 188 KB

Prediction of Combined Symptomatic and F

Prediction of Combined Symptomatic and Functional Outcome in Patients with Schizophrenia or Schizoaffective Disorder

✍ I. Lipkovich; W. Deberdt; P.F. Buckley; J.G. Csernansky; J. Peuskens; S. Kollack 📂 Article 📅 2006 🏛 American Society for Experimental NeuroTherapeutic 🌐 English ⚖ 43 KB

Outcomes and Costs of Risperidone versus

Outcomes and Costs of Risperidone versus Olanzapine in Patients with Chronic Schizophrenia or Schizoaffective Disorders: A Markov Model

✍ Montserrat Vera-Llonch; Thomas E Delea; Erin Richardson; Marcia Rupnow; Amy Grog 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 138 KB